Delcath Systems, Inc. reported a revenue increase to $0.4 million for the first quarter of 2021, compared to $0.3 million in the prior year. However, the company recorded a net loss of $6.8 million, a shift from the net income of $7.9 million in the same period of 2020. The company's cash and cash equivalents totaled $26.7 million.
Product revenue increased to $0.4 million compared to $0.3 million in the prior year period.
Selling, general, and administrative expenses rose to $3.3 million from $2.3 million in the prior year quarter.
Research and development expenses increased to $3.7 million compared to $3.0 million in the prior year quarter.
Net loss was $6.8 million, compared to a net income of $7.9 million for the same period in 2020.
Delcath anticipates continued progress throughout the year, focusing on filing an NDA in early 2022 and expanding HEPZATO development into areas with high unmet needs.